NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
8-K - Prelude Therapeutics Inc - 1.01 / 8.01 / 9.01
Filed:
2026-04-21
AccNo:
0001193125-26-164510
Size:
513 KB
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
发布时间04/20 23:04 UTC
首次发现04/21 10:06 UTC
热度82.2
重要度78
情绪+0.02
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 728 字符
Form 8-K - Current report: SEC Accession No. 0001193125-26-164510
Filing Date: 2026-04-21
Accepted: 2026-04-20 19:04:03
Documents: 17
Period of Report: 2026-04-20
Items: Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Prelude Therapeutics Inc (Filer) CIK : 0001678660 (see all company filings) EIN. : 811384762 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 26876393 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | d131537d8k.htm iXBRL | 8-K
2 | EX-1.1 | d131537dex11.htm | EX-1.1
3 | EX-4.1 | d131537dex41.htm | EX-4.1
4 | EX-5.1 | d131537dex51.htm | EX-5.1